Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity

Description

The goal of this proposal is to develop novel HH-SECTR technology for visualizing and quantifying diagnostic disease features in prematurely born infant retinopathy of prematurity (ROP) patients that lead to more informed clinical decision making. Providing depth-resolved vascular information has not been adequately investigated for its diagnostic potential. Furthermore, we seek to identify disease features not currently accessible by standard examination methods to better inform clinical decisions.

Conditions

Retinopathy of Prematurity (ROP), ROP Examination

Study Overview

Study Details

Study overview

The goal of this proposal is to develop novel HH-SECTR technology for visualizing and quantifying diagnostic disease features in prematurely born infant retinopathy of prematurity (ROP) patients that lead to more informed clinical decision making. Providing depth-resolved vascular information has not been adequately investigated for its diagnostic potential. Furthermore, we seek to identify disease features not currently accessible by standard examination methods to better inform clinical decisions.

Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity

Point-of-Care Ophthalmic Diagnostic Imaging of Retinopathy of Prematurity

Condition
Retinopathy of Prematurity (ROP)
Intervention / Treatment

-

Contacts and Locations

Nashville

Vanderbilt University Medical Center, Nashville, Tennessee, United States, 37232

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Preterm male and female infants born at 24-34 weeks gestational age and weighing \<1500g at birth
  • * Infants surgically treated for ROP
  • * Infants with significant health concern that would preclude noninvasive retinal imaging as noted by the primary inpatient team

Ages Eligible for Study

24 Weeks to 34 Weeks

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

Vanderbilt University Medical Center,

Study Record Dates

2030-02